Publications by authors named "A A Bhalodi"

Article Synopsis
  • * Dental and eye examinations were conducted by specialists to identify periodontal disease and specific types of AMD in 200 participants, using standardized criteria.
  • * Findings revealed that factors like age, education level, income, hypertension, cardiovascular disease, and hepatitis B are significantly associated with AMD, particularly in individuals under 60.
View Article and Find Full Text PDF

Introduction: Previous studies noted varied adherence to clinical practice guidelines (CPGs), but studies are yet to quantify adherence to American Urological Association BPH guidelines. We studied guideline adherence in the context of a new quality improvement collaborative (QIC).

Methods: Data were collected as part of a statewide QIC.

View Article and Find Full Text PDF
Article Synopsis
  • The Clinical and Laboratory Standards Institute (CLSI) updated its guidelines, suggesting that cefazolin is a better predictor for susceptibility to cephalosporins in uncomplicated urinary tract infections (uUTIs) compared to cephalothin.
  • A new cefazolin surrogacy breakpoint has been established to help predict susceptibility for seven oral cephalosporins in the context of uUTIs.
  • The implementation of this cefazolin breakpoint presents challenges for clinical labs, requiring a review of historical data, pharmacokinetics, and clinical outcomes related to its use.
View Article and Find Full Text PDF

Background: Bloodstream infections (BSIs) are a leading cause of morbidity and mortality. The Improving Outcomes and Antimicrobial Stewardship study seeks to evaluate the impact of the Accelerate PhenoTest BC Kit (AXDX) on antimicrobial use and clinical outcomes in BSIs.

Methods: This multicenter, quasiexperimental study compared clinical and antimicrobial stewardship metrics, prior to and after implementation of AXDX, to evaluate the impact this technology has on patients with BSIs.

View Article and Find Full Text PDF

Antimicrobial susceptibility testing for Pseudomonas aeruginosa is critical to determine suitable treatment options. Commercial susceptibility tests are typically calibrated against the reference method, broth microdilution (BMD). Imprecision of MICs obtained by BMD for the same isolate on repeat testing is known to exist.

View Article and Find Full Text PDF